{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:54:18Z","timestamp":1792896858873,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NYU Cancer Institute Cancer Center Support","award":["P30CA016087"],"award-info":[{"award-number":["P30CA016087"]}]},{"name":"NYU Melanoma SPORE","award":["P50CA016087"],"award-info":[{"award-number":["P50CA016087"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The American Joint Committee on Cancer (AJCC) maintains that the eighth edition of its Staging Manual (AJCC8) has improved accuracy compared with the seventh (AJCC7). However, there are concerns that implementation may disrupt analysis of active clinical trials for stage III patients. We used an independent cohort of melanoma patients to test the extent to which AJCC8 has improved prognostic accuracy compared with AJCC7.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed a cohort of 1315 prospectively enrolled patients. We assessed primary tumor and nodal classification of stage I\u2013III patients using AJCC7 and AJCC8 to assign disease stages at diagnosis. We compared recurrence-free (RFS) and overall survival (OS) using Kaplan-Meier curves and log-rank tests. We then compared concordance indices of discriminatory prognostic ability and area under the curve of 5-year survival to predict RFS and OS. All statistical tests were two-sided.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Stage IIC patients continued to have worse outcomes than stage IIIA patients, with a 5-year RFS of 26.5% (95% confidence interval [CI]\u2009=\u200912.8% to 55.1%) vs 56.0% (95% CI\u2009=\u200937.0% to 84.7%) by AJCC8 (P\u2009=\u2009.002). For stage I, removing mitotic index as a T classification factor decreased its prognostic value, although not statistically significantly (RFS concordance index [C-index]\u2009=\u20090.63, 95% CI\u2009=\u20090.56 to 0.69; to 0.56, 95% CI\u2009=\u20090.49 to 0.63, P\u2009=\u2009.07; OS C-index\u2009=\u20090.48, 95% CI\u2009=\u20090.38 to 0.58; to 0.48, 95% CI\u2009=\u20090.41 to 0.56, P\u2009=\u2009.90). For stage II, prognostication remained constant (RFS C-index\u2009=\u20090.65, 95% CI\u2009=\u20090.57 to 0.72; OS C-index\u2009=\u20090.61, 95% CI\u2009=\u20090.50 to 0.72), and for stage III, AJCC8 yielded statistically significantly enhanced prognostication for RFS (C-index\u2009=\u20090.65, 95% CI\u2009=\u20090.60 to 0.70; to 0.70, 95% CI\u2009=\u20090.66 to 0.75, P\u2009=\u2009.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with AJCC7, we demonstrate that AJCC8 enables more accurate prognosis for patients with stage III melanoma. Restaging a large cohort of patients can enhance the analysis of active clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djaa008","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T15:10:17Z","timestamp":1579705817000},"page":"921-928","source":"Crossref","is-referenced-by-count":57,"title":["Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition"],"prefix":"10.1093","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-7170","authenticated-orcid":false,"given":"Shirin","family":"Bajaj","sequence":"first","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Call","sequence":"additional","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-8327","authenticated-orcid":false,"given":"Paul","family":"Johannet","sequence":"additional","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una","family":"Moran","sequence":"additional","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9554-5289","authenticated-orcid":false,"given":"David","family":"Polsky","sequence":"additional","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, New York, NY, USA"},{"name":"Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Berman","sequence":"additional","affiliation":[{"name":"Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pavlick","sequence":"additional","affiliation":[{"name":"Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Weber","sequence":"additional","affiliation":[{"name":"Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Langone School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-1971","authenticated-orcid":false,"given":"Iman","family":"Osman","sequence":"additional","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"2020101314044655900_djaa008-B1","first-page":"131","year":"1977","journal-title":"Manual for Staging of Cancer"},{"key":"2020101314044655900_djaa008-B2","first-page":"117","volume-title":"Manual for Staging of Cancer","year":"1983","edition":"2nd ed."},{"key":"2020101314044655900_djaa008-B3","first-page":"139","volume-title":"Manual for Staging of Cancer","year":"1988","edition":"3rd ed"},{"key":"2020101314044655900_djaa008-B4","first-page":"143","volume-title":"Manual for Staging of Cancer","year":"1992","edition":"4th ed"},{"key":"2020101314044655900_djaa008-B5","first-page":"163","volume-title":"Manual for Staging of Cancer","year":"1997","edition":"5th ed"},{"key":"2020101314044655900_djaa008-B6","first-page":"209","volume-title":"Manual for Staging of Cancer","year":"2002","edition":"6th"},{"key":"2020101314044655900_djaa008-B7","first-page":"325","volume-title":"Manual for Staging of Cancer","year":"2009","edition":"7th ed."},{"key":"2020101314044655900_djaa008-B8","first-page":"563","volume-title":"Manual for Staging of Cancer","year":"2017","edition":"8th ed."},{"key":"2020101314044655900_djaa008-B9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejca.2017.11.023","article-title":"Eighth American Joint Committee on Cancer (AJCC) melanoma classification: let us reconsider stage III","volume":"91","author":"Grob","year":"2018","journal-title":"Eur J Cancer"},{"issue":"6","key":"2020101314044655900_djaa008-B10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2020101314044655900_djaa008-B11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/sim.6370","article-title":"Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach","volume":"34","author":"Kang","year":"2015","journal-title":"Stat Med"},{"key":"2020101314044655900_djaa008-B12","volume-title":"SEER Cancer Statistics Review, 1975-2016.","author":"Howlader"},{"issue":"9","key":"2020101314044655900_djaa008-B13","first-page":"910","article-title":"Mitotic rate in primary melanoma: interobserver and intraobserver reliability, analyzed using H&E sections and immunohistochemistry","volume":"14","author":"Garbe","year":"2016","journal-title":"J Dtsch Dermatol Ges."},{"issue":"12","key":"2020101314044655900_djaa008-B14","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/00000478-200312000-00011","article-title":"Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas","volume":"27","author":"Scolyer","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2020101314044655900_djaa008-B15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2015.11.026","article-title":"The burden of malignant melanoma\u2014lessons to be learned from Austria","volume":"56","author":"Monshi","year":"2016","journal-title":"Eur J Cancer"},{"issue":"2","key":"2020101314044655900_djaa008-B16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","article-title":"Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013","volume":"76","author":"Landow","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2020101314044655900_djaa008-B17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/CLEP.S99021","article-title":"Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe\u2014a systematic review of the literature","volume":"8","author":"Svedman","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"2","key":"2020101314044655900_djaa008-B18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/CMR.0000000000000312","article-title":"Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland","volume":"27","author":"Minini","year":"2017","journal-title":"Melanoma Res"},{"issue":"1","key":"2020101314044655900_djaa008-B19","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv294","article-title":"Melanoma thickness and survival trends in the United States, 1989 to 2009","volume":"108","author":"Shaikh","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2020101314044655900_djaa008-B20","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (1 mm) than from thick melanomas (&gt;4 mm) in Queensland, Australia","volume":"135","author":"Whiteman","year":"2015","journal-title":"J Inves Dermatol"},{"issue":"1","key":"2020101314044655900_djaa008-B21","doi-asserted-by":"crossref","first-page":"e180083","DOI":"10.1001\/jamanetworkopen.2018.0083","article-title":"Concordance and reproducibility of melanoma staging according to the 7th vs 8th edition of the AJCC Cancer Staging Manual","volume":"1","author":"Elmore","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2020101314044655900_djaa008-B22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejca.2017.10.031","article-title":"Improved stratification of pT1 melanoma\u00a0according to the 8th American Joint Committee on Cancer Staging Edition criteria: a Dutch population-based study","volume":"92","author":"Verver","year":"2018","journal-title":"Eur J Cancer"},{"key":"2020101314044655900_djaa008-B23","doi-asserted-by":"crossref","first-page":"j2813","DOI":"10.1136\/bmj.j2813","article-title":"The reproducibility and accuracy of pathologists\u2019 diagnosis of invasive melanoma and melanocytic proliferations","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"},{"issue":"8","key":"2020101314044655900_djaa008-B24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/cup.13265","article-title":"Influence of variability in assessment of Breslow thickness, mitotic rate and ulceration among US pathologists interpreting invasive melanoma, for the purpose of AJCC staging","volume":"45","author":"Taylor","year":"2018","journal-title":"J Cutan Pathol"},{"key":"2020101314044655900_djaa008-B25","article-title":"Deep learning based on standard H&E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death","author":"Prathamesh","journal-title":"Clin Cancer Res"},{"issue":"22","key":"2020101314044655900_djaa008-B26","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.2017.14585","article-title":"Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer","volume":"318","author":"Ehteshami Bejnordi","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"2020101314044655900_djaa008-B27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41379-018-0073-z","article-title":"Using deep convolutional neural networks to identify and classify tumor-associated stroma in diagnostic breast biopsies","volume":"31","author":"Ehteshami Bejnordi","year":"2018","journal-title":"Mod Pathol"},{"key":"2020101314044655900_djaa008-B28","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1109\/TMI.2018.2820199","article-title":"Whole-slide mitosis detection in H&E breast histology using PHH3 as a reference to train distilled stain-invariant convolutional networks","author":"Tellez","year":"2018","journal-title":"IEEE Trans Med Imaging"},{"issue":"10","key":"2020101314044655900_djaa008-B29","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","article-title":"Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning","volume":"24","author":"Coudray","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"2020101314044655900_djaa008-B30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/neuonc\/nos113","article-title":"Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site","volume":"14","author":"Ma","year":"2012","journal-title":"Neuro Oncol"},{"issue":"19","key":"2020101314044655900_djaa008-B31","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"2020101314044655900_djaa008-B32","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"2020101314044655900_djaa008-B33","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"2020101314044655900_djaa008-B34","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/bjd.17145","article-title":"Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC?","volume":"179","author":"Brancaccio","year":"2018","journal-title":"Br J Dermatol"},{"issue":"12","key":"2020101314044655900_djaa008-B35","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1016\/S1470-2045(18)30596-5","article-title":"Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?","volume":"19","author":"Grob","year":"2018","journal-title":"Lancet Oncol"},{"key":"2020101314044655900_djaa008-B36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2019.01.103","article-title":"Embracing changes to the American Joint Committee on Cancer 8th Edition Melanoma Staging System","volume":"112","author":"Haydu","year":"2019","journal-title":"Eur J Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djaa008\/33153640\/djaa008.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/112\/9\/921\/33878522\/djaa008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/112\/9\/921\/33878522\/djaa008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T16:19:58Z","timestamp":1602605998000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/112\/9\/921\/5715587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,1,24]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaa008","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,1,24]]}}}